Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "Birla Roy Gnanamuthu"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
Clinicopathological Study of 18 Cases of Inflammatory Myofibroblastic Tumors with Reference to ALK-1 Expression: 5-Year Experience in a Tertiary Care Center
Ramesh Babu Telugu, Anne Jennifer Prabhu, Nobin Babu Kalappurayil, John Mathai, Birla Roy Gnanamuthu, Marie Therese Manipadam
J Pathol Transl Med. 2017;51(3):255-263.   Published online April 17, 2017
DOI: https://doi.org/10.4132/jptm.2017.01.12
  • 10,878 View
  • 377 Download
  • 19 Web of Science
  • 23 Crossref
AbstractAbstract PDF
Background
Inflammatory myofibroblastic tumor is a histopathologically distinctive neoplasm of children and young adults. According to World Health Organization (WHO) classification, inflammatory myofibroblastic tumor is an intermediate-grade tumor, with potential for recurrence and rare metastasis. There are no definite histopathologic, molecular, or cytogenetic features to predict malignant transformation, recurrence, or metastasis.
Methods
A 5-year retrospective study of histopathologically diagnosed inflammatory myofibroblastic tumors of various anatomic sites was conducted to correlate anaplastic lymphoma kinase-1 (ALK-1) expression with histological atypia, multicentric origin of tumor, recurrence, and metastasis. Clinical details of all the cases were noted from the clinical work station. Immunohistochemical stains for ALK-1 and other antibodies were performed. Statistical analysis was done using Fisher exact test.
Results
A total of 18 cases of inflammatory myofibroblastic tumors were found during the study period, of which 14 were classical. The female-male ratio was 1:1 and the mean age was 23.8 years. Histologically atypical (four cases) and multifocal tumors (three cases, multicentric in origin) were noted. Recurrence was noted in 30% of ALK-1 positive and 37.5% of ALK-1 negative cases, whereas metastasis to the lung, liver, and pelvic bone was noted in the ALK-1 positive group only.
Conclusions
Overall, ALK-1 protein was expressed in 55.6% of inflammatory myofibroblastic tumors. There was no statistically significant correlation between ALK-1 expression, tumor type, recurrence and metastasis. However, ALK-1 immunohistochemistry is a useful diagnostic aid in the appropriate clinical and histomorphologic context.

Citations

Citations to this article as recorded by  
  • Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib
    Mengmeng Li, Ruyue Xing, Jiuyan Huang, Chao Shi, Chunhua Wei, Huijuan Wang
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Inflammatory Myofibroblastic Tumour of the Sinonasal Tract with Orbital and Intracranial Extensions Simulating a Malignancy: A Case Report and Review of Literature
    Gaveshani Mantri, Subhalaxmi Rautray, Rahul Mohanty, Vinushree Karakkandy
    Indian Journal of Otolaryngology and Head & Neck Surgery.2022; 74(S2): 1668.     CrossRef
  • Clinical, pathologic, and molecular features of inflammatory myofibroblastic tumors in children and adolescents
    Aurore Pire, Daniel Orbach, Louise Galmiche, Dominique Berrebi, Sabine Irtan, Sabah Boudjemaa, Hervé J. Brisse, Laureline Berteloot, Salma Moalla, Charlotte Mussini, Pascale Philippe‐Chomette, Bogdana Tilea, Gaelle Pierron, Florent Guerin, Véronique Minar
    Pediatric Blood & Cancer.2022;[Epub]     CrossRef
  • Case Report: Early Distant Metastatic Inflammatory Myofibroblastic Tumor Harboring EML4-ALK Fusion Gene: Study of Two Typical Cases and Review of Literature
    Qianqian Han, Xin He, Lijuan Cui, Yan Qiu, Yuli Li, Huijiao Chen, Hongying Zhang
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Inflammatory myofibroblastic tumor: A multi‐institutional study from the Pediatric Surgical Oncology Research Collaborative
    Barrie S. Rich, Joanna Fishbein, Timothy Lautz, Nathan S. Rubalcava, Tanvi Kartal, Erika Newman, Pei En Wok, Rodrigo L. P. Romao, Richard Whitlock, Bindi Naik‐Mathuria, Stephanie F. Polites, Katrine Løfberg, Danny Lascano, Eugene Kim, Jacob Davidson, Andr
    International Journal of Cancer.2022; 151(7): 1059.     CrossRef
  • Child inflammatory myofibroblastic tumor of the kidney misdiagnosed as Wilms' tumor: case report
    Yu-Feng Bai, Jing-Zhong Liu, Li-Na Yue, Li Chen, Sui-Yi Liu, Rui Liu
    Radiology Case Reports.2022; 17(12): 4920.     CrossRef
  • A Common Cell of Origin for Inflammatory Myofibroblastic Tumor and Lung Adenocarcinoma with ALK rearrangement
    Vasyl Nesteryuk, Omar Hamdani, Raymond Gong, Nava Almog, Brian M. Alexander, Steffan Soosman, Ken Yoneda, Siraj M. Ali, Alexander D. Borowsky, Jonathan W. Riess
    Clinical Lung Cancer.2022; 23(8): e550.     CrossRef
  • An extremely rare case of malignant jejunal mesenteric inflammatory myofibroblastic tumor in a 61-year-old male patient: A case report and literature review
    Hamdi Al Shenawi, Salamah A. Al-Shaibani, Suhair K. Al Saad, Fedaa Al-Sindi, Khalid Al-Sindi, Noor Al Shenawi, Yahya Naguib, Rami Yaghan
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Primary inflammatory myofibroblastic tumor of stomach—report of a very rare case
    Ranendra Hajong, Kewithinwangbo Newme, Donkupar Khongwar
    Journal of Family Medicine and Primary Care.2021; 10(1): 552.     CrossRef
  • Complicated course of biliary inflammatory myofibroblastic tumor mimicking hilar cholangiocarcinoma: A case report and literature review
    Sandra Strainiene, Kotryna Sedleckaite, Juozas Jarasunas, Ilona Savlan, Juozas Stanaitis, Ieva Stundiene, Tomas Strainys, Valentina Liakina, Jonas Valantinas
    World Journal of Clinical Cases.2021; 9(21): 6155.     CrossRef
  • Epithelioid Inflammatory Myofibroblastic Sarcoma Presenting as Gastrointestinal Bleed: Case Report and Literature Review
    Alexandra Giannaki, Dimitrios Doganis, Panagiota Giamarelou, Anastasia Konidari
    JPGN Reports.2021; 2(1): e019.     CrossRef
  • Complete response to alectinib following crizotinib in an ALK-positive inflammatory myofibroblastic tumor with CNS involvement
    Camila B. Xavier, Felipe S.N.A. Canedo, Fabíola A.S. Lima, Raíssa R. Melo, Luiz Guilherme C.A. Lima, José Flávio G. Marin, Ciro E. Souza, Olavo Feher
    Current Problems in Cancer: Case Reports.2021; 4: 100117.     CrossRef
  • Urinary Bladder Inflammatory Myofibroblastic Tumor With Mutated TP53 and PPFIBP1-ALK Gene Fusion
    Andreia N. Barbieri, Christopher T. Tallman, Raj Satkunasivam, Joseph Annunziata, Jessica S. Thomas, Randall J. Olsen, Steven S. Shen, Michael J. Thrall, Mary R. Schwartz
    AJSP: Reviews and Reports.2021; 26(1): 45.     CrossRef
  • Therapeutic options in inoperable ROS1-rearranged inflammatory myofibroblastic tumor of the tongue in a child: a case report and literature review
    Malgorzata Styczewska, Agastya Patel, Joanna Jaskulowska, Jan Godzinski, Dominik Swieton, Bartosz Wasag, Juliea Dass, Ewa Bien, Malgorzata A. Krawczyk
    Anti-Cancer Drugs.2021; 32(10): 1111.     CrossRef
  • Non-squamous cell carcinoma diseases of the larynx: clinical and imaging findings
    Serap Doğan, Alperen Vural, Güven Kahriman, Hakan İmamoğlu, Ümmühan Abdülrezzak, Mustafa Öztürk
    Brazilian Journal of Otorhinolaryngology.2020; 86(4): 468.     CrossRef
  • Successful treatment of pulmonary inflammatory myofibroblastic tumor with platinum‐pemetrexed: The first report of two cases
    Xiaoyan Si, Hanping Wang, Xiaotong Zhang, Mengzhao Wang, Yan You, Li Zhang
    Thoracic Cancer.2020; 11(8): 2339.     CrossRef
  • Rare presentation of inflammatory myofibroblastic tumor in the kidney
    Hiba Abduljawad, Ahmet Aslan, Khalifa Aldoseri, Erdem Yilmaz, Wael Ibrahim
    Radiology Case Reports.2020; 15(8): 1266.     CrossRef
  • Histopathological landscape of rare oesophageal neoplasms
    Gianluca Businello, Carlo Alberto Dal Pozzo, Marta Sbaraglia, Luca Mastracci, Massimo Milione, Luca Saragoni, Federica Grillo, Paola Parente, Andrea Remo, Elena Bellan, Rocco Cappellesso, Gianmaria Pennelli, Mauro Michelotto, Matteo Fassan
    World Journal of Gastroenterology.2020; 26(27): 3865.     CrossRef
  • Laryngeal Inflammatory Myofibroblastic Tumor : Case Series and Literature Review
    Ki-Ik Park, Sung-hoon Kim, In-Suh Park, Ji Won Kim
    Journal of The Korean Society of Laryngology, Phoniatrics and Logopedics.2019; 30(1): 57.     CrossRef
  • Anaplastic lymphoma kinase-negative pulmonary inflammatory myofibroblastic tumor with multiple metastases and its treatment by Apatinib
    Qiuxia Liu, Jianguo Wei, Xizhong Liu, Jianfang Wang
    Medicine.2019; 98(52): e18414.     CrossRef
  • Inflammatory myofibroblastic tumor
    Veronika Marcináková, Hana Dittrichová, Karel Franěk, Pavel Hanek
    Urologie pro praxi.2019; 20(1): 40.     CrossRef
  • Ureteral inflammatory myofibroblastic tumor
    Faping Li, Hui Guo, Heping Qiu, Yuchuan Hou
    Medicine.2018; 97(46): e13177.     CrossRef
  • Pulmonary inflammatory myofibroblastic tumour misdiagnosed as a round pneumonia
    Samira Naime, Anjum Bandarkar, Gustavo Nino, Geovanny Perez
    BMJ Case Reports.2018; : bcr-2017-224091.     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine